1. Biochemistry and Chemical Biology
  2. Structural Biology and Molecular Biophysics

Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2

  1. Brandon Wey-Hung Liauw
  2. Arash Foroutan
  3. Michael R Schamber
  4. Weifeng Lu
  5. Hamid Samareh Afsari  Is a corresponding author
  6. Reza Vafabakhsh  Is a corresponding author
  1. Northwestern University, United States
  2. Boehringer Ingelheim Pharmaceuticals, Inc, United States
https://doi.org/10.7554/eLife.78982
Share this article
Cite this article
  1. Brandon Wey-Hung Liauw
  2. Arash Foroutan
  3. Michael R Schamber
  4. Weifeng Lu
  5. Hamid Samareh Afsari
  6. Reza Vafabakhsh
(2022)
Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
eLife 11:e78982.
https://doi.org/10.7554/eLife.78982
  2. Download BibTeX
  3. Download .RIS

Abstract

Activation of G protein-coupled receptors (GPCRs) is an allosteric process. It involves conformational coupling between the orthosteric ligand binding site and the G protein binding site. Factors that bind at non-cognate ligand binding sites to alter the allosteric activation process are classified as allosteric modulators and represent a promising class of therapeutics with distinct modes of binding and action. For many receptors, how modulation of signaling is represented at the structural level is unclear. Here, we developed FRET sensors to quantify receptor modulation at each of the three structural domains of metabotropic glutamate receptor 2 (mGluR2). We identified the conformational fingerprint for several allosteric modulators in live cells. This approach enabled us to derive a receptor-centric representation of allosteric modulation and to correlate structural modulation to the standard signaling modulation metrics. Single-molecule FRET analysis revealed that a NAM increases the occupancy of one of the intermediate states while a PAM increases the occupancy of the active state. Moreover, we found that the effect of allosteric modulators on the receptor dynamics is complex and depend on the orthosteric ligand. Collectively, our findings provide a structural mechanism of allosteric modulation in mGluR2 and suggest possible strategies for design of future modulators.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Accompanying source data is provided for figures 1-4 and tables 1-3. The PDB accession codes for human mGluR2 structures used are 7MTS, 7MTR, 7E9G, 7EPE, and 7EPF.

The following previously published data sets were used

Article and author information

Author details

  1. Brandon Wey-Hung Liauw

    Department of Molecular Biosciences, Northwestern University, Evanston, United States
    Competing interests
    No competing interests declared.

  2. Arash Foroutan

    Department of Molecular Biosciences, Northwestern University, Evanston, United States
    Competing interests
    No competing interests declared.

  3. Michael R Schamber

    Department of Molecular Biosciences, Northwestern University, Evanston, United States
    Competing interests
    No competing interests declared.

  4. Weifeng Lu

    Department of Molecular Biosciences, Northwestern University, Evanston, United States
    Competing interests
    No competing interests declared.

  5. Hamid Samareh Afsari

    Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, United States
    For correspondence
    hamid.samareh_afsari@boehringer-ingelheim.com
    Competing interests
    Hamid Samareh Afsari, is affiliated with Boehringer Ingelheim Pharma GmbH & Co. The author has no financial interests to declare..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5839-4765

  6. Reza Vafabakhsh

    Department of Molecular Biosciences, Northwestern University, Evanston, United States
    For correspondence
    reza.vafabakhsh@northwestern.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8384-3203

Funding

NIGMS (R01GM140272)

  • Reza Vafabakhsh

NIGMS (T32GM-008061)

  • Brandon Wey-Hung Liauw

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Marcel P Goldschen-Ohm, University of Texas at Austin, United States

Version history

  1. Received: March 26, 2022
  2. Preprint posted: April 28, 2022 (view preprint)
  3. Accepted: June 30, 2022
  4. Accepted Manuscript published: July 1, 2022 (version 1)
  5. Version of Record published: July 20, 2022 (version 2)

Copyright

© 2022, Liauw et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,852
    views
  • 421
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Brandon Wey-Hung Liauw
  2. Arash Foroutan
  3. Michael R Schamber
  4. Weifeng Lu
  5. Hamid Samareh Afsari
  6. Reza Vafabakhsh
(2022)
Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
eLife 11:e78982.
https://doi.org/10.7554/eLife.78982

Share this article

https://doi.org/10.7554/eLife.78982

Categories and tags

Further reading

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression

    Human DDX6 regulates translation and decay of inefficiently translated mRNAs

    Ramona Weber, Chung-Te Chang
    Research Article

    Recent findings indicate that the translation elongation rate influences mRNA stability. One of the factors that has been implicated in this link between mRNA decay and translation speed is the yeast DEAD-box helicase Dhh1p. Here, we demonstrated that the human ortholog of Dhh1p, DDX6, triggers the deadenylation-dependent decay of inefficiently translated mRNAs in human cells. DDX6 interacts with the ribosome through the Phe-Asp-Phe (FDF) motif in its RecA2 domain. Furthermore, RecA2-mediated interactions and ATPase activity are both required for DDX6 to destabilize inefficiently translated mRNAs. Using ribosome profiling and RNA sequencing, we identified two classes of endogenous mRNAs that are regulated in a DDX6-dependent manner. The identified targets are either translationally regulated or regulated at the steady-state-level and either exhibit signatures of poor overall translation or of locally reduced ribosome translocation rates. Transferring the identified sequence stretches into a reporter mRNA caused translation- and DDX6-dependent degradation of the reporter mRNA. In summary, these results identify DDX6 as a crucial regulator of mRNA translation and decay triggered by slow ribosome movement and provide insights into the mechanism by which DDX6 destabilizes inefficiently translated mRNAs.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics

    Special Issue: Allosteric regulation of kinase activity

    Amy H Andreotti, Volker Dötsch
    Editorial

    The articles in this special issue highlight how modern cellular, biochemical, biophysical and computational techniques are allowing deeper and more detailed studies of allosteric kinase regulation.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy

    Carlo Giannangelo, Matthew P Challis ... Darren J Creek
    Research Article

    New antimalarial drug candidates that act via novel mechanisms are urgently needed to combat malaria drug resistance. Here, we describe the multi-omic chemical validation of Plasmodium M1 alanyl metalloaminopeptidase as an attractive drug target using the selective inhibitor, MIPS2673. MIPS2673 demonstrated potent inhibition of recombinant Plasmodium falciparum (PfA-M1) and Plasmodium vivax (PvA-M1) M1 metalloaminopeptidases, with selectivity over other Plasmodium and human aminopeptidases, and displayed excellent in vitro antimalarial activity with no significant host cytotoxicity. Orthogonal label-free chemoproteomic methods based on thermal stability and limited proteolysis of whole parasite lysates revealed that MIPS2673 solely targets PfA-M1 in parasites, with limited proteolysis also enabling estimation of the binding site on PfA-M1 to within ~5 Å of that determined by X-ray crystallography. Finally, functional investigation by untargeted metabolomics demonstrated that MIPS2673 inhibits the key role of PfA-M1 in haemoglobin digestion. Combined, our unbiased multi-omic target deconvolution methods confirmed the on-target activity of MIPS2673, and validated selective inhibition of M1 alanyl metalloaminopeptidase as a promising antimalarial strategy.